As a result, we conduct this randomised controlled trial to validate the hypothesis how the individualised antiplatelet therapy selected based on a combined mix of genetic info and clinical features would result in better clinical outcomes weighed against the typical care based just about clinical features in individuals with AIMS or TIA

As a result, we conduct this randomised controlled trial to validate the hypothesis how the individualised antiplatelet therapy selected based…